GlassScriptPhysician profile
William F Mandell
NPI 1770555088
$3,088.66
in general payments reported to CMS, 2019-2025
19 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $229 · 2021: $338 · 2022: $624 · 2023: $636 · 2024: $549 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,387.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,125.19 | 2019-2025 | Veklury |
| Viiv Healthcare Company | $896.48 | 2020-2025 | Apretude, Dovato, Rukobia |
| Merck Sharp & Dohme LLC | $237.67 | 2019-2024 | Dificid, Pifeltro, Delstrigo |
| Abbvie INC. | $173.40 | 2021-2025 | |
| Hologic Sales and Service, LLC | $132.53 | 2024-2025 | Aptima |
| Allergan, INC. | $101.94 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $91.24 | 2022-2023 | Quviviq |
| Napo Pharmaceuticals INC | $46.49 | 2022-2025 | Mytesi |
| Novo Nordisk INC | $33.29 | 2025 | |
| Theratechnologies INC. | $32.50 | 2021 | |
| Philips North America LLC | $28.00 | 2024 | (Ck7) Extended Holter |
| Otsuka America Pharmaceutical, INC. | $27.90 | 2023 | Rexulti, Abilify Asimtufii |
| Janssen Biotech, INC. | $27.61 | 2020 | |
| Axsome Therapeutics, INC. | $26.46 | 2024 | Auvelity |
| Daiichi Sankyo INC. | $23.42 | 2024 | Injectafer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $22.38 | 2023 | Shingrix |
| Sanofi-Aventis U.S. LLC | $22.12 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $20.95 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mandell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.